Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yuhudie Melasma Ointment Phase III Trial
CTR20234118Phase 3Terminated
- Sponsor
- Hangzhou Qianjin Pharmaceutical Co., Ltd.
- Start
- Dec 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Yuhudie Melasma Ointment in melasma, sponsored by Hangzhou Qianjin Pharmaceutical Co., Ltd.. Started Dec 2023; status: terminated.
02
Drugs
Yuhudie Melasma Ointment
03
Conditions
melasma
Beyond the preview
Go deeper on CTR20234118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20234118.